Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neutropenia 5Breast Neoplasms 5Febrile Neutropenia 3Wilms Tumor 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Malignant Solid Tumors 1Lymphoma 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breastcancer 1Breast Cancer Female 1

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1olaparib 1Topotecan 1SAR125844 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Solid Tumors × pegylated granulocyte colony-stimulating factor × Clear all
NCT02805166 2016-06-17

PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase 4 Completed
420 enrolled
Other solid neoplasm

Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡